speb/financial-data huggingface dataset:
UCL cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
UCL cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 2519000.00
UCL income_statement (annual, 2022-12-31) — Net Income: -19853000.00
UCL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -19853000.00
UCL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -19853000.00
UCL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -19853000.00
UCL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -19853000.00
UCL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -19853000.00
UCL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -19853000.00
UCL cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -14000.00
UCL income_statement (annual, 2022-12-31) — Net Interest Income: -423000.00
UCL cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -3000.00
UCL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 3540000.00
UCL cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -401000.00
UCL income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -423000.00
UCL balance_sheet (annual, 2022-12-31) — Net PPE: 1387000.00
UCL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -145000.00
UCL cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 3941000.00
UCL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 8489000.00
UCL balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 688000.00
UCL income_statement (annual, 2022-12-31) — Normalized EBITDA: -3080000.00
UCL income_statement (annual, 2022-12-31) — Normalized Income: -8131784.00
UCL cash_flow (annual, 2022-12-31) — Operating Cash Flow: 4404000.00
UCL cash_flow (annual, 2022-12-31) — Operating Gains Losses: 2232000.00
UCL income_statement (annual, 2022-12-31) — Operating Income: -3992000.00
UCL income_statement (annual, 2022-12-31) — Operating Revenue: 71461000.00
UCL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 368759100.00
UCL balance_sheet (annual, 2022-12-31) — Other Current Assets: 163000.00
UCL balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 34000.00
UCL balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 708000.00
UCL balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 1876000.00
UCL income_statement (annual, 2022-12-31) — Other Gand A: 18726000.00
UCL income_statement (annual, 2022-12-31) — Other Income Expense: -15349000.00
UCL balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 802000.00
UCL balance_sheet (annual, 2022-12-31) — Other Investments: 1711000.00
UCL cash_flow (annual, 2022-12-31) — Other Non Cash Items: 590000.00
UCL balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 204000.00
UCL income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -87000.00
UCL income_statement (annual, 2022-12-31) — Other Operating Expenses: -935000.00
UCL balance_sheet (annual, 2022-12-31) — Other Properties: 9251000.00
UCL balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 11887000.00
UCL income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
UCL balance_sheet (annual, 2022-12-31) — Payables: 8774000.00
UCL balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 31619000.00
UCL balance_sheet (annual, 2022-12-31) — Prepaid Assets: 3377000.00
UCL income_statement (annual, 2022-12-31) — Pretax Income: -19764000.00
UCL cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
UCL balance_sheet (annual, 2022-12-31) — Properties: 0.00
UCL cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 2014000.00
UCL cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
UCL cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -14000.00
UCL cash_flow (annual, 2022-12-31) — Purchase Of Investment: -3000.00
UCL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -411000.00
UCL balance_sheet (annual, 2022-12-31) — Raw Materials: 1971000.00
UCL balance_sheet (annual, 2022-12-31) — Receivables: 7374000.00
UCL income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 38927000.00
UCL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 981000.00
UCL cash_flow (annual, 2022-12-31) — Repayment Of Debt: -10903000.00
UCL income_statement (annual, 2022-12-31) — Research And Development: 8430000.00
UCL balance_sheet (annual, 2022-12-31) — Retained Earnings: -229377000.00
UCL cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
UCL cash_flow (annual, 2022-12-31) — Sale Of PPE: 266000.00
UCL income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 10305000.00
UCL income_statement (annual, 2022-12-31) — Selling General And Administration: 29031000.00
UCL balance_sheet (annual, 2022-12-31) — Share Issued: 368759100.00
UCL cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 14443000.00
UCL cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -10502000.00
UCL income_statement (annual, 2022-12-31) — Special Income Charges: 215000.00
UCL cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3098000.00
UCL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 9291000.00
UCL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 8489000.00
UCL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -3540784.00
UCL income_statement (annual, 2022-12-31) — Tax Provision: 161000.00
UCL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
UCL balance_sheet (annual, 2022-12-31) — Taxes Receivable: 715000.00
UCL balance_sheet (annual, 2022-12-31) — Total Assets: 45934000.00
UCL balance_sheet (annual, 2022-12-31) — Total Capitalization: 9291000.00
UCL balance_sheet (annual, 2022-12-31) — Total Debt: 3060000.00
UCL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 9291000.00
UCL income_statement (annual, 2022-12-31) — Total Expenses: 75453000.00
UCL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 36643000.00
UCL balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 4588000.00
UCL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 204000.00
UCL income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -19192000.00
UCL balance_sheet (annual, 2022-12-31) — Total Tax Payable: 461000.00
UCL income_statement (annual, 2022-12-31) — Total Unusual Items: -15262000.00
UCL income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -15262000.00
UCL cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 12958000.00
UCL balance_sheet (annual, 2022-12-31) — Working Capital: 4907000.00
UCL income_statement (annual, 2023-12-31) — +Operating Expense: 36758000.00
UCL income_statement (annual, 2023-12-31) — +Total Revenue: 85576000.00
UCL balance_sheet (annual, 2023-12-31) — Accounts Payable: 5314000.00
UCL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 6489000.00
UCL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -10022000.00
UCL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 240137000.00
UCL balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -4201000.00
UCL cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 136000.00
UCL cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 136000.00
UCL cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 657000.00
UCL income_statement (annual, 2023-12-31) — Basic Average Shares: 37172632.00
UCL income_statement (annual, 2023-12-31) — Basic EPS: 0.10
UCL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 14921000.00
UCL cash_flow (annual, 2023-12-31) — Capital Expenditure: -2065000.00
UCL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2368000.00
UCL balance_sheet (annual, 2023-12-31) — Capital Stock: 19000.00
UCL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 23371000.00
UCL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 30984000.00
UCL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 2509000.00
UCL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -240000.00
UCL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 6507000.00
UCL cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -691000.00
UCL cash_flow (annual, 2023-12-31) — Change In Inventory: 784000.00
UCL cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 10000.00
UCL cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 373000.00
UCL cash_flow (annual, 2023-12-31) — Change In Payable: -231000.00
UCL cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -922000.00
UCL cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -1713000.00
UCL cash_flow (annual, 2023-12-31) — Change In Receivables: -2637000.00
UCL cash_flow (annual, 2023-12-31) — Change In Working Capital: -4105000.00
UCL cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -390000.00
UCL cash_flow (annual, 2023-12-31) — Changes In Cash: 8776000.00
UCL balance_sheet (annual, 2023-12-31) — Common Stock: 19000.00
UCL balance_sheet (annual, 2023-12-31) — Common Stock Equity: 16053000.00
UCL income_statement (annual, 2023-12-31) — Cost Of Revenue: 43611000.00
UCL balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 23374000.00
UCL balance_sheet (annual, 2023-12-31) — Current Assets: 49017000.00
UCL balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1082000.00
UCL balance_sheet (annual, 2023-12-31) — Current Debt: 5297000.00
UCL balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 6379000.00
UCL balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 1425000.00
UCL balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 1425000.00
UCL balance_sheet (annual, 2023-12-31) — Current Liabilities: 39123000.00
UCL cash_flow (annual, 2023-12-31) — Depreciation: 985000.00
UCL cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1121000.00
UCL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1121000.00
UCL income_statement (annual, 2023-12-31) — Diluted Average Shares: 37172632.00
UCL income_statement (annual, 2023-12-31) — Diluted EPS: 0.10
UCL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 2811000.00
UCL cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 83000.00
UCL balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 2945000.00
UCL balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 1250000.00
UCL income_statement (annual, 2023-12-31) — EBIT: 2657000.00
UCL income_statement (annual, 2023-12-31) — EBITDA: 3778000.00
UCL income_statement (annual, 2023-12-31) — Earnings From Equity Interest Net Of Tax: 357000.00
UCL cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -357000.00
UCL cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -326000.00
UCL cash_flow (annual, 2023-12-31) — End Cash Position: 23371000.00
UCL cash_flow (annual, 2023-12-31) — Financing Cash Flow: 2509000.00
UCL balance_sheet (annual, 2023-12-31) — Finished Goods: 1909000.00
UCL cash_flow (annual, 2023-12-31) — Free Cash Flow: 4442000.00
UCL cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -203000.00
UCL income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 203000.00
UCL income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -3262000.00
UCL balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 2463000.00
UCL income_statement (annual, 2023-12-31) — General And Administrative Expense: 17118000.00
UCL balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 652000.00
UCL balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 10690000.00
UCL balance_sheet (annual, 2023-12-31) — Gross PPE: 14776000.00
UCL income_statement (annual, 2023-12-31) — Gross Profit: 41965000.00
UCL income_statement (annual, 2023-12-31) — Interest Expense: 133000.00
UCL income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 133000.00
UCL income_statement (annual, 2023-12-31) — Interest Income: 70000.00
UCL income_statement (annual, 2023-12-31) — Interest Income Non Operating: 70000.00
UCL cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 133000.00
UCL balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -1381000.00
UCL balance_sheet (annual, 2023-12-31) — Inventory: 2183000.00
UCL balance_sheet (annual, 2023-12-31) — Invested Capital: 21350000.00
UCL cash_flow (annual, 2023-12-31) — Investing Cash Flow: -240000.00
UCL balance_sheet (annual, 2023-12-31) — Investments And Advances: 1956000.00
UCL cash_flow (annual, 2023-12-31) — Issuance Of Debt: 7910000.00
UCL balance_sheet (annual, 2023-12-31) — Leases: 531000.00
UCL balance_sheet (annual, 2023-12-31) — Line Of Credit: 2756000.00
UCL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1286000.00
UCL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1286000.00
UCL cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -34000.00
UCL balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 2236000.00
UCL cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
UCL cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 514000.00
UCL income_statement (annual, 2023-12-31) — Net Income: 2811000.00
UCL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 2811000.00
UCL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 2811000.00
UCL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 2811000.00
UCL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 2811000.00
UCL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 2811000.00
UCL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 2811000.00
UCL cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
UCL income_statement (annual, 2023-12-31) — Net Interest Income: -63000.00
UCL cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 1525000.00
UCL cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 2460000.00
UCL cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -34000.00
UCL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -63000.00
UCL balance_sheet (annual, 2023-12-31) — Net PPE: 4754000.00
UCL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1848000.00
UCL cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 2494000.00
UCL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 15401000.00
UCL balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 228000.00
UCL income_statement (annual, 2023-12-31) — Normalized EBITDA: 6837000.00
UCL income_statement (annual, 2023-12-31) — Normalized Income: 5785162.44
UCL cash_flow (annual, 2023-12-31) — Operating Cash Flow: 6507000.00
UCL cash_flow (annual, 2023-12-31) — Operating Gains Losses: -46000.00
UCL income_statement (annual, 2023-12-31) — Operating Income: 5207000.00
UCL income_statement (annual, 2023-12-31) — Operating Revenue: 85576000.00
UCL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 374485700.00
UCL balance_sheet (annual, 2023-12-31) — Other Current Assets: 196000.00
UCL balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 2541000.00
UCL balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1036000.00
UCL balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 2463000.00
UCL income_statement (annual, 2023-12-31) — Other Gand A: 17118000.00
UCL income_statement (annual, 2023-12-31) — Other Income Expense: -2620000.00
UCL balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 652000.00
UCL balance_sheet (annual, 2023-12-31) — Other Investments: 1956000.00
UCL cash_flow (annual, 2023-12-31) — Other Non Cash Items: 133000.00
UCL balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 145000.00
UCL income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 439000.00
UCL income_statement (annual, 2023-12-31) — Other Operating Expenses: -1120000.00
UCL balance_sheet (annual, 2023-12-31) — Other Properties: 12009000.00
UCL balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 7613000.00
UCL balance_sheet (annual, 2023-12-31) — Payables: 6909000.00
UCL balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 30283000.00
UCL balance_sheet (annual, 2023-12-31) — Prepaid Assets: 5159000.00
UCL income_statement (annual, 2023-12-31) — Pretax Income: 2524000.00
UCL cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 49000.00
UCL balance_sheet (annual, 2023-12-31) — Properties: 0.00
UCL cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -126000.00
UCL cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
UCL cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
UCL cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
UCL cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2065000.00
UCL balance_sheet (annual, 2023-12-31) — Raw Materials: 1655000.00
UCL balance_sheet (annual, 2023-12-31) — Receivables: 10495000.00
UCL income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 43611000.00
UCL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1121000.00
UCL cash_flow (annual, 2023-12-31) — Repayment Of Debt: -5450000.00
UCL income_statement (annual, 2023-12-31) — Research And Development: 6456000.00
UCL balance_sheet (annual, 2023-12-31) — Retained Earnings: -226566000.00
UCL cash_flow (annual, 2023-12-31) — Sale Of Investment: 1525000.00
UCL cash_flow (annual, 2023-12-31) — Sale Of PPE: 217000.00
UCL income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 14304000.00
UCL income_statement (annual, 2023-12-31) — Selling General And Administration: 31422000.00
UCL balance_sheet (annual, 2023-12-31) — Share Issued: 374485700.00
UCL cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 7910000.00
UCL cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -5416000.00
UCL income_statement (annual, 2023-12-31) — Special Income Charges: 203000.00
UCL cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3314000.00
UCL balance_sheet (annual, 2023-12-31) — Stockholders Equity: 16053000.00
UCL balance_sheet (annual, 2023-12-31) — Tangible Book Value: 15401000.00
UCL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -84837.56
UCL income_statement (annual, 2023-12-31) — Tax Provision: 70000.00
UCL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.03
UCL balance_sheet (annual, 2023-12-31) — Taxes Receivable: 1061000.00
UCL balance_sheet (annual, 2023-12-31) — Total Assets: 56607000.00
UCL balance_sheet (annual, 2023-12-31) — Total Capitalization: 16053000.00
UCL balance_sheet (annual, 2023-12-31) — Total Debt: 7665000.00
UCL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 16053000.00
UCL income_statement (annual, 2023-12-31) — Total Expenses: 80369000.00
UCL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 40554000.00
UCL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 7590000.00
UCL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1431000.00
UCL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 2587000.00
UCL balance_sheet (annual, 2023-12-31) — Total Tax Payable: 345000.00
UCL income_statement (annual, 2023-12-31) — Total Unusual Items: -3059000.00
UCL income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -3059000.00
UCL cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 2748000.00
UCL balance_sheet (annual, 2023-12-31) — Working Capital: 9894000.00
UCL balance_sheet (quarterly, 2024-09-30) — Non Current Prepaid Assets: 0.00
UCL income_statement (annual, 2024-12-31) — +Operating Expense: 41123000.00
UCL income_statement (annual, 2024-12-31) — +Total Revenue: 91635000.00
UCL balance_sheet (annual, 2024-12-31) — Accounts Payable: 7445000.00
UCL balance_sheet (annual, 2024-12-31) — Accounts Receivable: 7880000.00
UCL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -8739000.00
UCL balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -8739000.00
UCL balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 241378000.00
UCL balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -4622000.00
UCL balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -4622000.00
UCL cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 137000.00
UCL cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 137000.00
UCL cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 106000.00
UCL income_statement (annual, 2024-12-31) — Basic Average Shares: 37634442.00
UCL income_statement (annual, 2024-12-31) — Basic EPS: 0.10
UCL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 23371000.00
UCL cash_flow (annual, 2024-12-31) — Capital Expenditure: -3998000.00
UCL balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2941000.00
UCL balance_sheet (annual, 2024-12-31) — Capital Stock: 19000.00
UCL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 30057000.00
UCL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 38760000.00
UCL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 1732000.00
UCL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -3758000.00
UCL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 9186000.00
UCL cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 2238000.00
UCL cash_flow (annual, 2024-12-31) — Change In Inventory: 766000.00
UCL cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -40000.00
UCL cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -717000.00
UCL cash_flow (annual, 2024-12-31) — Change In Payable: -1202000.00
UCL cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1036000.00
UCL cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1009000.00
UCL cash_flow (annual, 2024-12-31) — Change In Receivables: -838000.00
UCL cash_flow (annual, 2024-12-31) — Change In Working Capital: 1216000.00
UCL cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1812000.00
UCL cash_flow (annual, 2024-12-31) — Changes In Cash: 7160000.00
UCL balance_sheet (annual, 2024-12-31) — Common Stock: 19000.00
UCL balance_sheet (annual, 2024-12-31) — Common Stock Equity: 21623000.00
UCL income_statement (annual, 2024-12-31) — Cost Of Revenue: 47274000.00
UCL balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 23234000.00
UCL balance_sheet (annual, 2024-12-31) — Current Assets: 55560000.00
UCL balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1853000.00
UCL balance_sheet (annual, 2024-12-31) — Current Debt: 6956000.00
UCL balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 8809000.00
UCL balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 709000.00
UCL balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 709000.00
UCL balance_sheet (annual, 2024-12-31) — Current Liabilities: 42181000.00
UCL cash_flow (annual, 2024-12-31) — Depreciation: 2191000.00
UCL cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2328000.00
UCL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2328000.00
UCL income_statement (annual, 2024-12-31) — Diluted Average Shares: 37634442.00
UCL income_statement (annual, 2024-12-31) — Diluted EPS: 0.10
UCL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 4558000.00
UCL cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 0.00
UCL balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 1971000.00
UCL balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 49000.00
UCL balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 49000.00
UCL income_statement (annual, 2024-12-31) — EBIT: 4612000.00
UCL income_statement (annual, 2024-12-31) — EBITDA: 6940000.00
UCL income_statement (annual, 2024-12-31) — Earnings From Equity Interest Net Of Tax: 210000.00
UCL cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -210000.00
UCL cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -474000.00
UCL cash_flow (annual, 2024-12-31) — End Cash Position: 30057000.00
UCL cash_flow (annual, 2024-12-31) — Financing Cash Flow: 1732000.00
UCL balance_sheet (annual, 2024-12-31) — Finished Goods: 1681000.00
UCL balance_sheet (quarterly, 2024-12-31) — Finished Goods: 1681000.00
UCL cash_flow (annual, 2024-12-31) — Free Cash Flow: 5188000.00
UCL cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -80000.00
UCL income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 80000.00
UCL income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 621000.00
UCL balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2234000.00
UCL income_statement (annual, 2024-12-31) — General And Administrative Expense: 15947000.00
UCL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 507000.00
UCL balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 12502000.00
UCL balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 12502000.00
UCL balance_sheet (annual, 2024-12-31) — Gross PPE: 15640000.00
UCL income_statement (annual, 2024-12-31) — Gross Profit: 44361000.00
UCL income_statement (annual, 2024-12-31) — Interest Expense: 196000.00
UCL income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 196000.00
UCL income_statement (annual, 2024-12-31) — Interest Income: 227000.00
UCL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 227000.00
UCL cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 196000.00
UCL balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -1486000.00
UCL balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -1486000.00
UCL balance_sheet (annual, 2024-12-31) — Inventory: 1312000.00
UCL balance_sheet (annual, 2024-12-31) — Invested Capital: 28579000.00
UCL cash_flow (annual, 2024-12-31) — Investing Cash Flow: -3758000.00
UCL balance_sheet (annual, 2024-12-31) — Investments And Advances: 2011000.00
UCL cash_flow (annual, 2024-12-31) — Issuance Of Debt: 6988000.00
UCL balance_sheet (annual, 2024-12-31) — Leases: 529000.00
UCL balance_sheet (quarterly, 2024-12-31) — Leases: 529000.00
UCL balance_sheet (annual, 2024-12-31) — Line Of Credit: 6956000.00
UCL balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 6956000.00
UCL balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1088000.00
UCL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1088000.00
UCL cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2504000.00
UCL balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2257000.00
UCL balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 2257000.00
UCL cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 470000.00
UCL income_statement (annual, 2024-12-31) — Net Income: 4558000.00
UCL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 4558000.00
UCL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 4558000.00
UCL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 4558000.00
UCL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 4558000.00
UCL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 4558000.00
UCL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 4558000.00
UCL cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
UCL income_statement (annual, 2024-12-31) — Net Interest Income: 31000.00
UCL cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
UCL cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 1732000.00
UCL cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -2504000.00
UCL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 31000.00
UCL balance_sheet (annual, 2024-12-31) — Net PPE: 6901000.00
UCL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -3758000.00
UCL cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 4236000.00
UCL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 21116000.00
UCL balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 0.00
UCL balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 0.00
UCL income_statement (annual, 2024-12-31) — Normalized EBITDA: 6239000.00
UCL income_statement (annual, 2024-12-31) — Normalized Income: 3867794.38
UCL cash_flow (annual, 2024-12-31) — Operating Cash Flow: 9186000.00
UCL cash_flow (annual, 2024-12-31) — Operating Gains Losses: 180000.00
UCL income_statement (annual, 2024-12-31) — Operating Income: 3238000.00
UCL income_statement (annual, 2024-12-31) — Operating Revenue: 91635000.00
UCL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 377971590.00
UCL balance_sheet (annual, 2024-12-31) — Other Current Assets: 361000.00
UCL balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1563000.00
UCL balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 1563000.00
UCL balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 2234000.00
UCL income_statement (annual, 2024-12-31) — Other Gand A: 15947000.00
UCL income_statement (annual, 2024-12-31) — Other Income Expense: 1147000.00
UCL balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 507000.00
UCL balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 507000.00
UCL balance_sheet (annual, 2024-12-31) — Other Investments: 2011000.00
UCL balance_sheet (quarterly, 2024-12-31) — Other Investments: 2011000.00
UCL cash_flow (annual, 2024-12-31) — Other Non Cash Items: 196000.00
UCL balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 87000.00
UCL income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 446000.00
UCL income_statement (annual, 2024-12-31) — Other Operating Expenses: -948000.00
UCL balance_sheet (annual, 2024-12-31) — Other Properties: 12854000.00
UCL balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 8703000.00
UCL balance_sheet (annual, 2024-12-31) — Payables: 7866000.00
UCL balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 31100000.00
UCL balance_sheet (annual, 2024-12-31) — Prepaid Assets: 3930000.00
UCL balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 3930000.00
UCL income_statement (annual, 2024-12-31) — Pretax Income: 4416000.00
UCL cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
UCL balance_sheet (annual, 2024-12-31) — Properties: 0.00
UCL balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
UCL cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 452000.00
UCL cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
UCL cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
UCL cash_flow (annual, 2024-12-31) — Purchase Of PPE: -3998000.00
UCL balance_sheet (annual, 2024-12-31) — Raw Materials: 1117000.00
UCL balance_sheet (quarterly, 2024-12-31) — Raw Materials: 1117000.00
UCL balance_sheet (annual, 2024-12-31) — Receivables: 11197000.00
UCL income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 47274000.00
UCL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2328000.00
UCL cash_flow (annual, 2024-12-31) — Repayment Of Debt: -5256000.00
UCL income_statement (annual, 2024-12-31) — Research And Development: 6198000.00
UCL balance_sheet (annual, 2024-12-31) — Retained Earnings: -222008000.00
UCL cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
UCL cash_flow (annual, 2024-12-31) — Sale Of PPE: 240000.00
UCL income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 19926000.00
UCL income_statement (annual, 2024-12-31) — Selling General And Administration: 35873000.00
UCL balance_sheet (annual, 2024-12-31) — Share Issued: 377971590.00
UCL cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 6988000.00
UCL cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -2752000.00
UCL income_statement (annual, 2024-12-31) — Special Income Charges: 80000.00
UCL cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1241000.00
UCL balance_sheet (annual, 2024-12-31) — Stockholders Equity: 21623000.00
UCL balance_sheet (annual, 2024-12-31) — Tangible Book Value: 21116000.00
UCL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 10794.38
UCL income_statement (annual, 2024-12-31) — Tax Provision: 68000.00
UCL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.02
UCL balance_sheet (annual, 2024-12-31) — Taxes Receivable: 1346000.00
UCL balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 1346000.00
UCL balance_sheet (annual, 2024-12-31) — Total Assets: 64979000.00
UCL balance_sheet (annual, 2024-12-31) — Total Capitalization: 21623000.00
UCL balance_sheet (annual, 2024-12-31) — Total Debt: 9897000.00
UCL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 21623000.00
UCL income_statement (annual, 2024-12-31) — Total Expenses: 88397000.00
UCL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 43356000.00
UCL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 9419000.00
UCL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1175000.00
UCL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 4385000.00
UCL balance_sheet (annual, 2024-12-31) — Total Tax Payable: 372000.00
UCL balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 372000.00
UCL income_statement (annual, 2024-12-31) — Total Unusual Items: 701000.00
UCL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 701000.00
UCL cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -1091000.00
UCL balance_sheet (annual, 2024-12-31) — Working Capital: 13379000.00
UCL income_statement (quarterly, 2025-03-31) — +Operating Expense: 10232000.00
UCL income_statement (quarterly, 2025-03-31) — +Total Revenue: 18749000.00
UCL balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 6934000.00
UCL balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 6098000.00
UCL balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 241707000.00
UCL income_statement (quarterly, 2025-03-31) — Basic Average Shares: 37622854.00
UCL income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
UCL cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 30057000.00
UCL balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2430000.00
UCL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 19000.00
UCL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 31075000.00
UCL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 39050000.00
UCL cash_flow (quarterly, 2025-03-31) — Changes In Cash: 862000.00
UCL balance_sheet (quarterly, 2025-03-31) — Common Stock: 19000.00
UCL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 21326000.00
UCL income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 9059000.00
UCL balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 23094000.00
UCL balance_sheet (quarterly, 2025-03-31) — Current Assets: 54349000.00
UCL balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1788000.00
UCL balance_sheet (quarterly, 2025-03-31) — Current Debt: 7941000.00
UCL balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 9729000.00
UCL balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 941000.00
UCL balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 941000.00
UCL balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 40698000.00
UCL income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 37622854.00
UCL income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
UCL income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -614000.00
UCL balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 1573000.00
UCL balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 0.00
UCL income_statement (quarterly, 2025-03-31) — EBIT: -467000.00
UCL income_statement (quarterly, 2025-03-31) — EBITDA: -467000.00
UCL income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest Net Of Tax: -3000.00
UCL cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 156000.00
UCL cash_flow (quarterly, 2025-03-31) — End Cash Position: 31075000.00
UCL cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 976000.00
UCL cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 236000.00
UCL balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2222000.00
UCL income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3140000.00
UCL balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 474000.00
UCL balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5904000.00
UCL income_statement (quarterly, 2025-03-31) — Gross Profit: 9690000.00
UCL income_statement (quarterly, 2025-03-31) — Interest Expense: 57000.00
UCL income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 57000.00
UCL income_statement (quarterly, 2025-03-31) — Interest Income: 5000.00
UCL income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 5000.00
UCL balance_sheet (quarterly, 2025-03-31) — Inventory: 2338000.00
UCL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 29267000.00
UCL cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -350000.00
UCL balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 2012000.00
UCL balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 642000.00
UCL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 642000.00
UCL income_statement (quarterly, 2025-03-31) — Net Income: -614000.00
UCL income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -614000.00
UCL income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -614000.00
UCL income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -614000.00
UCL income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -614000.00
UCL income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -614000.00
UCL income_statement (quarterly, 2025-03-31) — Net Interest Income: -52000.00
UCL income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -52000.00
UCL balance_sheet (quarterly, 2025-03-31) — Net PPE: 5904000.00
UCL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 20852000.00
UCL income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -467000.00
UCL income_statement (quarterly, 2025-03-31) — Normalized Income: -614000.00
UCL cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 236000.00
UCL income_statement (quarterly, 2025-03-31) — Operating Income: -542000.00
UCL income_statement (quarterly, 2025-03-31) — Operating Revenue: 18749000.00
UCL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 377971590.00
UCL balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 5290000.00
UCL balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 7941000.00
UCL balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 2222000.00
UCL income_statement (quarterly, 2025-03-31) — Other Gand A: 3140000.00
UCL income_statement (quarterly, 2025-03-31) — Other Income Expense: 70000.00
UCL balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 73000.00
UCL income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 70000.00
UCL balance_sheet (quarterly, 2025-03-31) — Other Properties: 5904000.00
UCL balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 7975000.00
UCL balance_sheet (quarterly, 2025-03-31) — Payables: 6934000.00
UCL balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 30028000.00
UCL income_statement (quarterly, 2025-03-31) — Pretax Income: -524000.00
UCL balance_sheet (quarterly, 2025-03-31) — Receivables: 7671000.00
UCL income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 9059000.00
UCL income_statement (quarterly, 2025-03-31) — Research And Development: 1399000.00
UCL balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -222622000.00
UCL income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 5693000.00
UCL income_statement (quarterly, 2025-03-31) — Selling General And Administration: 8833000.00
UCL balance_sheet (quarterly, 2025-03-31) — Share Issued: 377971590.00
UCL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 21326000.00
UCL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 20852000.00
UCL income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
UCL income_statement (quarterly, 2025-03-31) — Tax Provision: 87000.00
UCL income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
UCL balance_sheet (quarterly, 2025-03-31) — Total Assets: 62739000.00
UCL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 21326000.00
UCL balance_sheet (quarterly, 2025-03-31) — Total Debt: 10371000.00
UCL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 21326000.00
UCL income_statement (quarterly, 2025-03-31) — Total Expenses: 19291000.00
UCL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 41413000.00
UCL balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 8390000.00
UCL balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 715000.00
UCL income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -472000.00
UCL balance_sheet (quarterly, 2025-03-31) — Working Capital: 13651000.00
UCL income_statement (quarterly, 2025-06-30) — +Operating Expense: 10432000.00
UCL income_statement (quarterly, 2025-06-30) — +Total Revenue: 19376000.00
UCL balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8015000.00
UCL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 6232000.00
UCL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 242087000.00
UCL income_statement (quarterly, 2025-06-30) — Basic Average Shares: 37717524.00
UCL income_statement (quarterly, 2025-06-30) — Basic EPS: 0.02
UCL cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 31075000.00
UCL balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1977000.00
UCL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 19000.00
UCL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 30204000.00
UCL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 38758000.00
UCL cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1027000.00
UCL balance_sheet (quarterly, 2025-06-30) — Common Stock: 19000.00
UCL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 22454000.00
UCL income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 9147000.00
UCL balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 21841000.00
UCL balance_sheet (quarterly, 2025-06-30) — Current Assets: 57369000.00
UCL balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1535000.00
UCL balance_sheet (quarterly, 2025-06-30) — Current Debt: 7962000.00
UCL balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 9497000.00
UCL balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 2410000.00
UCL balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 2410000.00
UCL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 41773000.00
UCL income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 37717524.00
UCL income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
UCL income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 678000.00
UCL balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 672000.00
UCL balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 10000.00
UCL income_statement (quarterly, 2025-06-30) — EBIT: 839000.00
UCL income_statement (quarterly, 2025-06-30) — EBITDA: 839000.00
UCL income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: -7000.00
UCL cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 156000.00
UCL cash_flow (quarterly, 2025-06-30) — End Cash Position: 30204000.00
UCL cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
UCL cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -877000.00
UCL balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2292000.00
UCL income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3363000.00
UCL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 500000.00
UCL balance_sheet (quarterly, 2025-06-30) — Gross PPE: 4849000.00
UCL income_statement (quarterly, 2025-06-30) — Gross Profit: 10229000.00
UCL income_statement (quarterly, 2025-06-30) — Interest Expense: 59000.00
UCL income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 59000.00
UCL income_statement (quarterly, 2025-06-30) — Interest Income: 31000.00
UCL income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 31000.00
UCL balance_sheet (quarterly, 2025-06-30) — Inventory: 4545000.00
UCL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 30416000.00
UCL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -150000.00
UCL balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2010000.00
UCL balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 442000.00
UCL balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 442000.00
UCL income_statement (quarterly, 2025-06-30) — Net Income: 678000.00
UCL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 678000.00
UCL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 678000.00
UCL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 678000.00
UCL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 678000.00
UCL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 678000.00
UCL income_statement (quarterly, 2025-06-30) — Net Interest Income: -28000.00
UCL income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -28000.00
UCL balance_sheet (quarterly, 2025-06-30) — Net PPE: 4849000.00
UCL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 21954000.00
UCL income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 839000.00
UCL income_statement (quarterly, 2025-06-30) — Normalized Income: 678000.00
UCL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -877000.00
UCL income_statement (quarterly, 2025-06-30) — Operating Income: -203000.00
UCL income_statement (quarterly, 2025-06-30) — Operating Revenue: 19376000.00
UCL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 377971590.00
UCL balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 7162000.00
UCL balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 7962000.00
UCL balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 2292000.00
UCL income_statement (quarterly, 2025-06-30) — Other Gand A: 3363000.00